Dr. Alexander George Dickinson Ph.D. serves as Independent Director of the Company. He is a director of the Company since August 2017, Dr. Dickinson is the executive chairman of ChromaCode, a private clinical diagnostics company. Previously Dr. Dickinson was the Senior Vice President of Strategic Initiatives at Illumina, Inc., a developer, manufacturer, and marketer of integrated systems for the analysis of genetic variation and biological function, where his responsibilities included working with national governments and large institutions to develop precision medicine programs for healthcare systems. Earlier he led the team that built Illumina's cloud-based sequencing informatics platform, BaseSpace, now one of the world's largest genomic databases. Dr. Dickinson joined Illumina in 2010 when the company acquired Helixis, a molecular diagnostics company that he led as Chief Executive Officer after co-founding with Caltech Professor Axel Scherer and Nobel Laureate David Baltimore. Dr. Dickinson was previously the founder and Chief Executive Officer of Luxtera, a leading provider of interconnect products for cloud computing that was acquired by Cisco Systems. He began his career as a researcher at AT&T Bell Labs and has been awarded over 40 patents covering a range of inventions including the camera and fingerprint CMOS chip technologies widely used in today's smartphones. Dr. Dickinson holds a Ph.D. from the University of Adelaide, Australia, and an MBA from Columbia University in New York.
As the Independent Director of PRA Health Sciences Inc, the total compensation of Alexander Dickinson at PRA Health Sciences Inc is 200,000$. There are 6 executives at PRA Health Sciences Inc getting paid more, with Colin Shannon having the highest compensation of 7,160,220$.
Alexander Dickinson is 58, he's been the Independent Director of PRA Health Sciences Inc since 2017. There are 4 older and 6 younger executives at PRA Health Sciences Inc. The oldest executive at PRA Health Sciences Inc is Jeffrey Barber, 67, who is the Independent Director.
Alexander's mailing address filed with the SEC is C/O PRA HEALTH SCIENCES, INC., 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH, NC, 27612.
Over the last 10 years, insiders at PRA Health Sciences Inc have traded over 5,843,308,181$ worth of PRA Health Sciences Inc stock. The most active insiders traders include Fund Holdings L.P.Kkr Fund ...、Fund Holdings L.P.Kkr Fund ...、Pra Investors L.P.Kkr Pra I.... On average, PRA Health Sciences Inc executives and independent directors trade stock every 39 days with the average trade being worth of 280,602,577$. The most recent stock trade was executed by Christopher L Gaenzle on 17 June 2021, trading 27,497 units of PRAH stock currently worth 2,773,897$.
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
PRA Health Sciences Inc executives and other stock owners filed with the SEC include: